6-chloro-2-(3-methylphenyl)quinoline-4-carboxylic acid, 95.0%, 1g

1-(4-Chloro-2-(5-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethan-1-one, 98+%, 10g

4-AMINO-2-CHLORONICOTINIC ACID, 95.0%, 100mg

3-Methyl-isonicotinamidine; hydrochloride, 95.0%, 1g

Ethyl 5-(trifluoromethoxy)indole-2-carboxylate, 97.0%, 250mg

1-({amino[(4-chlorophenyl)amino]methylidene}amino)-N-(propan-2-yl)methanimidamide, 97%, 100mg

1-Ethylpyrrolidine>98.0%(GC)5g

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 95+%, 250mg

Diethyl L-(+)-Tartrate>98.0%(GC)500g

1-Fluoro-3-iodobenzene, 99.0%, 1g

Anti-radiation box SEKUROKA® Antibeta Screens, Maxi, 300 x 185 x 160 mm, 1 Piece

2-(4-(((tert-Butoxycarbonyl)amino)methyl)phenyl)acetic acid, 95.0%, 5g

3-(3-aminophenyl)-1,3-oxazolidin-2-one, 95.0%, 1g